A cost-effectiveness analysis of the 13-valent pneumococcal conjugated vaccine and the 23-valent pneumococcal polysaccharide vaccine among Thai older adult

A cost-effectiveness analysis of the 13-valent pneumococcal conjugated vaccine and the 23-valent pneumococcal polysaccharide vaccine among Thai older adult

IntroductionThis study aims to assess the economic impact of introducing the 13-valent pneumococcal conjugate vaccine (PCV13) and 23-valent pneumococcal polysaccharide vaccine (PPSV23) to Thai older adult aged ≥ 65  years who are healthy or with chronic health conditions and immunocompromised condit...

Full description

Bibliographic Details
Main Authors: Thundon Ngamprasertchai, Chayanis Kositamongkol, Saranath Lawpoolsri, Pinyo Rattanaumpawan, Viravarn Luvira, Piriyaporn Chongtrakool, Jaranit Kaewkungwal, Kulkanya Chokephaibulkit, Pochamana Phisalprapa
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-06-01
Series:Frontiers in Public Health
Subjects:
13-valent pneumococcal conjugated vaccine (PCV13)
23-valent pneumococcal polysaccharide vaccine (PPSV23)
cost-effectiveness
economic evaluation
Thailand
older adult
Online Access:https://www.frontiersin.org/articles/10.3389/fpubh.2023.1071117/full

Internet

https://www.frontiersin.org/articles/10.3389/fpubh.2023.1071117/full

Similar Items